Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

2.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.2K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.2K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

5.4K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.4K
Nociception01:44

Nociception

33.5K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
33.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Learned spatially varying microscopy model with adaptive point spread functions.

Optics express·2026
Same author

Excessive inhibition in the medial prefrontal cortex contributes to cognitive susceptibility in aging.

Neurobiology of disease·2026
Same author

Changes in the cortical GABAergic inhibitory system in a Spinal Muscular Atrophy mouse model.

Cell death & disease·2026
Same author

From Ornamental Value to Antioxidant Activity: Comparative Phytochemistry of <i>Lavandula</i> Species and Cultivars.

Metabolites·2026
Same author

Recommendations for the inclusion and study of sex and gender in research.

Nature neuroscience·2025
Same author

Valorisation of mediterranean basin fruit by-products: bioactive composition, applications, and future research directions.

Natural product research·2025
Same journal

Peripheral B-cell receptor repertoire predicts immune-related adverse events following immune checkpoint inhibitor therapy in advanced renal cell carcinoma.

Scientific reports·2026
Same journal

Effects of black soldier fly (Hermetia illucens L.) larvae zoocompost on the mineral element content of blue honeysuckle berries.

Scientific reports·2026
Same journal

Investigation on absorption refrigeration performance of R1243zf with imidazolium ionic liquid as the working pairs.

Scientific reports·2026
Same journal

DeepTriage-CN: integrating clinical text with vital signs for emergency department admission prediction in an aging population.

Scientific reports·2026
Same journal

Gold nanoparticles as dual-action antiviral agents: disruption of SARS-CoV-2 viral envelopes and RNA integrity.

Scientific reports·2026
Same journal

Comparison of capillary microsampling and venous blood for multi-pathogen serosurveillance.

Scientific reports·2026
See all related articles

Related Experiment Video

Updated: Feb 28, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.2K

Enhancing KCC2 function counteracts morphine-induced hyperalgesia.

Francesco Ferrini1,2, Louis-Etienne Lorenzo2, Antoine G Godin2

  • 1Department of Veterinary Sciences, University of Turin, Turin, Italy.

Scientific Reports
|June 22, 2017
PubMed
Summary
This summary is machine-generated.

Enhancing the chloride extruder KCC2 with CLP257 or CLP290 counteracts morphine-induced hyperalgesia (MIH) by restoring spinal GABAergic inhibition. This approach may improve pain management by preventing and reversing MIH.

More Related Videos

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.9K

Related Experiment Videos

Last Updated: Feb 28, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

34.2K
Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
Intracranial Pharmacotherapy and Pain Assays in Rodents
02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

5.9K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Morphine-induced hyperalgesia (MIH) is a detrimental side effect of repeated morphine use.
  • MIH is linked to reduced KCC2 chloride extruder expression in the spinal cord, impairing inhibitory neurotransmission.

Purpose of the Study:

  • To investigate if KCC2-enhancing small molecules (CLP257 and CLP290) can counteract MIH.
  • To assess the therapeutic potential of targeting KCC2 for pain management.

Main Methods:

  • Morphine treatment in rats to induce hyperalgesia.
  • Measurement of nociceptive thresholds and vocalizing behavior.
  • Assessment of chloride extrusion in spinal cord neurons.
  • Administration of CLP257 and CLP290 in vitro and in vivo.

Main Results:

  • Morphine treatment led to decreased mechanical withdrawal thresholds and increased vocalization.
  • Impaired chloride extrusion was observed in spinal cord neurons of morphine-treated rats.
  • CLP257 restored chloride extrusion in spinal cord slices.
  • Co-administration of CLP290 with morphine prevented KCC2 downregulation and mitigated MIH.
  • CLP257 reversed established MIH in vivo.

Conclusions:

  • Enhancing KCC2 activity is a promising strategy for counteracting MIH.
  • Chloride extrusion enhancers like CLP290 and CLP257 show potential as co-adjuvants to morphine therapy.
  • These agents could improve morphine analgesia by preventing and reversing MIH.